Pluri Inc. (PLUR) stock
PLURNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
$1.05−0.04 (-3.67%)
Close on Nov 13, 2026Market cap $12.96MP/E –Yield –
Pluri ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Pluri's ebitda for the twelve months ending Sep 30, 2026 was -$33.65M. For fiscal 2026 it was -$24.43M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$24.43M | – |
| FY2025 | Jun 30, 2025 | -$21.86M | – |
| FY2024 | Jun 30, 2024 | -$21.91M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | -$15.44M | – |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$5.42M | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$6.41M | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$6.38M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$6.22M | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$6.51M | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$5.33M | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$4.89M | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$5.13M | – |
See a number that looks wrong?